Oklo Founders Sold $10.5M Four Days Before Revenue Beat
Oklo reported $1.2 million in Q2 2026 revenue against an $83,800 consensus, a 14x beat that sent shares up 14% to $48.21, while co-founders and the CFO had sold $10.5 million in stock four days earlie
Oklo Posts First Revenue as Co-Founders Exit Before Beat
NEW YORK, August 7 —
Oklo Inc. (OKLO) reported $1.2 million in Q2 2026 revenue on August 7, a 14x beat on analyst consensus. Shares jumped 14% to $48.21 after the revenue beat and a reactor criticality announcement, above every price at which both co-founders and the CFO had sold four days prior.
- Q2 2026 revenue of $1.2M beat the $83,800 consensus; net loss widened to $48.5M, nearly double the year-ago $24.7M.
- CEO Dewitte, COO Cochran, and CFO Bealmear collectively sold approximately $10.5M in shares on August 3, four days before earnings.
- Net insider selling over the 90 days through August 4: $32.48M; zero purchases recorded during the period.
The Selling Pattern
CEO Jacob Dewitte and COO Caroline Cochran each sold approximately 120,000 shares on August 3 in six tranches apiece, at $38.55, $41.68 per Form 4 filings. CFO Richard Craig Bealmear sold 16,452 shares at $38.80 on the same date. The co-founders had run the same play on July 1, liquidating 200,000 shares each at $52.30, $53.71 for roughly $10.6 million apiece. Those July exits now sit above today's post-rally price of $48.21, meaning the founders found better prices on the way up than the market has managed since. Net insider selling over the 90 days through August 4: $32.48 million, zero purchases.
A Reactor, But Not the One That Matters
The Groves milestone that drove Thursday's rally deserves context. Achieving first criticality on August 5 makes it the first DOE Reactor Pilot Program project to reach criticality from a greenfield private-land site in less than a year of construction. But Groves is an isotopes test reactor, not an Aurora commercial power project. Oklo's business is selling 15-75 megawatt Aurora Powerhouse units to U.S. electricity customers and commercializing nuclear fuel recycling. The Groves facility proves execution capability; it contributes nothing to closing the gap between $1.2 million in Q2 revenue and the $48.5 million net loss incurred the same quarter.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| OKLO | $8.4B | n/a | -45.3% |
| SMR | $4.0B | n/a | -77.1% |
| NNE | $1.0B | n/a | -50.4% |
| CRWV | $49.5B | n/a | -33.8% |
| NBIS | $47.7B | n/a | +209.1% |
| IONQ | $16.6B | n/a | -7.2% |
What Breaks the Rally Thesis
Three things make today's 14% move fragile. First, the headline revenue beat rests against a $48.5 million quarterly loss, nearly double the year-ago burn. Second, Oklo has missed EPS estimates in three of the last four quarters, with negative surprises as large as 74.8%; Thursday's $0.28 miss against a $0.16 consensus extends the streak. Third, the founders' July exits at $52-53 now sit above the post-rally price, suggesting they found a better ceiling than today's buyers are assuming. The thesis changes when quarterly revenue sustains above $10 million, modelable via Oklo's DCF calculator. Run the free Oklo Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Did Oklo beat revenue estimates in Q2 2026?
Oklo reported $1.2 million in Q2 2026 revenue against an analyst consensus of $83,800, a 14x beat. Despite the revenue beat, net loss widened to $48.5 million, nearly double the year-ago $24.7 million. The company also missed EPS estimates, posting a $0.28 loss against a $0.16 consensus.
Did Oklo insiders sell shares before earnings?
CEO Jacob Dewitte and COO Caroline Cochran each sold approximately 120,000 shares on August 3, four days before the August 7 earnings release, at prices of $38.55 to $41.68 per Form 4 filings. CFO Richard Craig Bealmear sold 16,452 shares on the same date at $38.80. Net insider selling over the 90 days through August 4 totaled $32.48 million, with zero purchases recorded.
What is the Oklo Groves reactor milestone?
Groves achieved first criticality on August 5, making it the first DOE Reactor Pilot Program project to reach criticality from a greenfield private-land site in less than a year of construction. However, Groves is an isotopes test reactor, not an Aurora commercial power project. The milestone proves execution capability but does not close the gap between $1.2 million in Q2 revenue and the $48.5 million net loss incurred the same quarter.
What does Oklo's Aurora power plant do?
Oklo's core business is selling 15 to 75 megawatt Aurora Powerhouse units to U.S. electricity customers and commercializing nuclear fuel recycling. The Groves test reactor is a separate isotopes program and does not contribute to Aurora commercial revenue. The article notes the thesis changes when quarterly revenue sustains above $10 million.
Why did Oklo stock jump 14% on August 7?
Shares rose 14% to $48.21 after Oklo reported a 14x revenue beat on Q2 2026 results and announced that the Groves reactor had achieved first criticality on August 5. The post-rally price of $48.21 remains below the $52.30 to $53.71 range at which co-founders Dewitte and Cochran each sold 200,000 shares on July 1.
Oklo reported its first meaningful quarterly revenue on August 7, 2026, and its Groves test reactor achieved first criticality two days earlier — yet both co-founders and the CFO had collectively sold shares in multiple tranches just four days before the results at prices between $38.55 and $41.68, below where the stock traded after the announcements.
Sources & Filings